tiprankstipranks
pc:duali

Dualitas Therapeutics Inc

Dualitas Therapeutics Inc. is a biotechnology company focused on developing next-generation bispecific antibody therapies for immunology and inflammation. Utilizing its proprietary DualScreen™ discovery engine, Dualitas is advancing a portfolio that includes lead programs DTX-103 for allergic diseases and DTX-102 for autoimmune diseases. The company aims to address unmet medical needs by leveraging novel cell-surface proximity mechanisms and strategic collaborations to enhance the therapeutic potential of its bispecific antibodies.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$65M
Total Amount Raised$65M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$65M
Latest Funding Amount$65M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 16, 2025
Series A
$65.00M

Related News and Analysis